[Photo] SillaJen Corporate Presentation
![[Photo] SillaJen Corporate Presentation](http://www.asiae.co.kr/news/img_view.htm?img=2022121310214149675_1670894501.jpg)
Shinragen, a medical and pharmaceutical research and development company, held a corporate briefing session at the Seoul Press Center on the 13th to discuss the current status of research and development and future plans. Executive Director Park Sang-geun is explaining the clinical status and plans for the next-generation anticancer virus. / Reporter Heo Young-han younghan@
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- [Why&Next] Uber and Naver Move to Acquire Baemin... Eyeing Coupang's Top Spot in Commerce
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
